Reckitt Benckiser Group

Reckitt Benckiser Group develops, acquires, produces, distributes and promotes consumer products in the health, hygiene and home categories. Co.'s health category covers treatment products such as pain and flu, and also wellness products in sexual wellbeing, footcare, vitamins and supplements. Co.'s hygiene category consists of personal and home hygiene products. Co.'s geographical segments comprise Europe (ENA) and Africa, Middle East (DvM). ENA comprises Europe, Russia/CIS, Israel, North America, Australia and New Zealand. DvM principally comprises North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, South Korea and ASEAN.
  • TickerRB.
  • ISINGB00B24CGK77
  • ExchangeLondon Stock Exchange
  • SectorHousehold Goods & Home Construction
  • CountryUnited Kingdom

Analysts

RECKITT BENCKISER GP.PLC sees an upgrade to Positive due to a better fundamental star rating

The general evaluation of RECKITT BENCKISER GP.PLC (GB), a company active in the Nondurable Household Products industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date March 15, 2019, the closing price was GBp 6,280.00 and its potential was estimated at GBp 6,717.55.

Reckitt Benckiser – Proxinvest Corporate Governance Rating ® : C

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

1 director bought

A director at Reckitt Benckiser Group bought 1,860 shares at 6,233p and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names o...

Philip Gorham

Morningstar | In Line 4Q for RB; Shares Undervalued but Margin Pressure May Be Sustained This Year

Reckitt Benckiser posted modest upside to our estimates in fourth-quarter 2018, with recovering like-for-like sales growth and solid operating income growth. Management guided to 3% to 4% like-for-like sales growth in 2019, in line with our forecasts, and we are maintaining our GBP 73 fair value estimate and wide moat rating. We see upside to the stock from current levels, and we think the strategy to reposition RB into a consumer health business will strengthen the business for the long run. Fourth-quarter like-for-like sales growth of 4% was modestly above our estimate, with upside in North...

Philip Gorham

Morningstar | In Line 4Q for RB; Shares Undervalued but Margin Pressure May Be Sustained This Year

Reckitt Benckiser posted modest upside to our estimates in fourth-quarter 2018, with recovering like-for-like sales growth and solid operating income growth. Management guided to 3% to 4% like-for-like sales growth in 2019, in line with our forecasts, and we are maintaining our GBP 73 fair value estimate and wide moat rating. We see upside to the stock from current levels, and we think the strategy to reposition RB into a consumer health business will strengthen the business for the long run. Fourth-quarter like-for-like sales growth of 4% was modestly above our estimate, with upside in North...

Reckitt Benckiser Group Plc - June 2018 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Reckitt Benckiser Group Plc: Update to credit analysis

Our credit view of Reckitt Benckiser, reflecting our deleveraging expectations towards 3.0x by 2019 through a combination of EBITDA growth and debt repayment.

Reckitt Benckiser Group Plc: Key Facts and Statistics - FYE December 2017

A summary company profile, detailing Reckitt Benckiser Group Plc’s business operations and financial highlights.

Reckitt Benckiser Group Plc - December 2017 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Reckitt Benckiser's Sale of Its Food Business Is Credit Positive

  ISSUER COMMENT  CORPORATES  JULY 24, 2017  Reckitt Benckiser’s Sale of Its Food Business Is  Credit Positive  From  Credit Outlook   On Thursday, UK multinational consumer goods company  Reckitt Benckiser Group PLC  (RB, A3  stable) annou

Philip Gorham

Morningstar | In Line 4Q for RB; Shares Undervalued but Margin Pressure May Be Sustained This Year

Reckitt Benckiser posted modest upside to our estimates in fourth-quarter 2018, with recovering like-for-like sales growth and solid operating income growth. Management guided to 3% to 4% like-for-like sales growth in 2019, in line with our forecasts, and we are maintaining our GBP 73 fair value estimate and wide moat rating. We see upside to the stock from current levels, and we think the strategy to reposition RB into a consumer health business will strengthen the business for the long run. Fourth-quarter like-for-like sales growth of 4% was modestly above our estimate, with upside in North...

Philip Gorham

Morningstar | In Line 4Q for RB; Shares Undervalued but Margin Pressure May Be Sustained This Year

Reckitt Benckiser posted modest upside to our estimates in fourth-quarter 2018, with recovering like-for-like sales growth and solid operating income growth. Management guided to 3% to 4% like-for-like sales growth in 2019, in line with our forecasts, and we are maintaining our GBP 73 fair value estimate and wide moat rating. We see upside to the stock from current levels, and we think the strategy to reposition RB into a consumer health business will strengthen the business for the long run. Fourth-quarter like-for-like sales growth of 4% was modestly above our estimate, with upside in North...

Philip Gorham

In Line 4Q for RB; Shares Undervalued but Margin Pressure May Be Sustained This Year

Reckitt Benckiser posted modest upside to our estimates in fourth-quarter 2018, with recovering like-for-like sales growth and solid operating income growth. Management guided to 3% to 4% like-for-like sales growth in 2019, in line with our forecasts, and we are maintaining our GBP 73 fair value estimate and wide moat rating. We see upside to the stock from current levels, and we think the strategy to reposition RB into a consumer health business will strengthen the business for the long run. Fo...

RB

RB

1 director bought

A director at Reckitt Benckiser Group bought 1,860 shares at 6,233p and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names o...

RECKITT BENCKISER GP.PLC sees an upgrade to Positive due to a better fundamental star rating

The general evaluation of RECKITT BENCKISER GP.PLC (GB), a company active in the Nondurable Household Products industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date March 15, 2019, the closing price was GBp 6,280.00 and its potential was estimated at GBp 6,717.55.

RB

RB

RB

RB

MarketLine Department

S.C. Johnson & Son Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's S.C. Johnson & Son Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by S.C. Johnson & Son Inc since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advan...

MarketLine Department

Emami Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Emami Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Emami Ltd since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highlights Thi...

MarketLine Department

Perrigo Company plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Perrigo Company plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Perrigo Company plc since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. ...

MarketLine Department

Church & Dwight Co Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Church & Dwight Co Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments Marketline's Church & Dwight Co Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Church & Dwight Co Inc since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and...

MarketLine Department

PZ Cussons Plc - Strategy, SWOT and Corporate Finance Report

Summary PZ Cussons Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights PZ Cussons Plc (PZ Cussons) is a manufacturer and marketer of consumer products. The company offers food and nutrition, electrical, personal care, baby care, and home care products. Its product portfolio includes detergents, soaps, toiletries, baby products, pharmaceuticals, nutritional produ...

Reckitt Benckiser – Proxinvest Corporate Governance Rating ® : C

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

Matthieu DRIOL

Analyse court terme - RECKITT BENCKISER : La tendance est incertaine.

La tendance est incertaine. Les cours baissent, et il y a une possibilité d'accélération baissière. Une nouvelle tendance baissière tente de démarrer.

Matthieu DRIOL

Short term view - RECKITT BENCKISER : The trend is uncertain.

The trend is uncertain. Prices are falling and they may accelerate to the downside. A new bearish trend is attempting to emerge.

Matthieu DRIOL

Analyse court terme - RECKITT BENCKISER : La tendance est incertaine.

La tendance est incertaine. Les cours baissent, mais la tendance manque de puissance pour le moment. Le prochain support est à 6 423,00 p.

Matthieu DRIOL

Short term view - RECKITT BENCKISER : The trend is uncertain.

The trend is uncertain. Prices are falling, but the trend is lacking power for the time being. The next support is at 6,423.00 p.

Jérôme VINERIER

Analyse moyen terme - RECKITT BENCKISER : La tendance de fond est clairement orientée à la hausse.

La tendance de fond est clairement orientée à la hausse. Les cours progressent toujours. Les objectifs suivants sont à 7 096,00 p et 7 912,00 p. La tendance serait invalidée sous le support à 5 090,00 p.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch